Representatives of our company, Maciej Gołaszewski and Maciej Tabiszewski, had the opportunity to participate in Arab Health 2025 at the Dubai World Trade Centre – one of the most important events in the medical industry in the Middle East. This prestigious event focuses on modern technologies, innovative ideas, and the experiences of experts from around the world.
BioCloner Health CEO Maciej Tabiszewski recently joined the InCredibles mentoring program.
Thank you for being with us.
A few months ago at the Warsaw University of Technology, the first implementation of the author’s Biocloner Desktop Pro took place. How are research using our …
Our company successfully implemented its original 3D bioprinting technology by introducing the BioCloner Desktop Pro at the Medical University of Warsaw (WUM) and the AGH University of Science and Technology in Kraków.
We are pleased to inform you that our Manufacturing Department has successfully passed the audit confirming the compliance of our quality management system with the PN-EN ISO 9001:2015 standard.
We are pleased to invite you to the upcoming webinar!
Together with our partner, Puredyne, we will discuss the topic: “Bioprinting Optimization: How New Technologies Enhance Precision and Efficiency in the Printing Process.”
Trzy intensywne dni na Economic Forum w Karpaczu dobiegły końca. Cieszymy się, że mogliśmy zaprezentować Wam nasze innowacyjne rozwiązania and autorskie biodrukarki 3D, który wzbudziły niemałe zainteresowanie.
In the coming days, we will have the pleasure of participating in the Economic Forum in Karpacz.
A few days ago, BioCloner Health board member, Maciej Gołaszewski, gave an interview for Wprost.
